Skip to main content
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
28.78
+1.08 (3.90%)
Nov 22, 2024, 4:00 PM EST - Market closed

Alkermes Revenue

Alkermes had revenue of $378.14M in the quarter ending September 30, 2024, a decrease of -0.73%. This brings the company's revenue in the last twelve months to $1.51B, down -5.37% year-over-year. In the year 2023, Alkermes had annual revenue of $1.66B with 49.61% growth.

Revenue (ttm)
$1.51B
Revenue Growth
-5.37%
P/S Ratio
3.07
Revenue / Employee
$716,724
Employees
2,100
Market Cap
4.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.96M-5.28%
Dec 31, 20211.17B134.99M13.00%
Dec 31, 20201.04B-132.19M-11.29%
Dec 31, 20191.17B76.67M7.01%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 8.22B
Select Medical Holdings 6.97B
Integer Holdings 1.71B
Stevanato Group 1.22B
Ultragenyx Pharmaceutical 522.75M
Axsome Therapeutics 338.46M
TG Therapeutics 264.79M
BridgeBio Pharma 217.77M
Revenue Rankings

ALKS News

More News